Ｄｅｌｔａ－Ｆｌｙ Ｐｈａｒｍａの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/26 | 1,258 | 1,267 | 1,130 | 1,194 | -64 | -5.1% | 1,168,300 |
| 2023/01/25 | 1,214 | 1,295 | 1,208 | 1,258 | +38 | +3.1% | 968,100 |
| 2023/01/24 | 1,242 | 1,265 | 1,197 | 1,220 | +7 | +0.6% | 899,800 |
| 2023/01/23 | 1,214 | 1,233 | 1,185 | 1,213 | -1 | -0.1% | 653,700 |
| 2023/01/20 | 1,130 | 1,228 | 1,130 | 1,214 | +66 | +5.7% | 537,600 |
| 2023/01/19 | 1,106 | 1,170 | 1,091 | 1,148 | +28 | +2.5% | 358,300 |
| 2023/01/18 | 1,089 | 1,131 | 1,068 | 1,120 | +1 | +0.1% | 499,800 |
| 2023/01/17 | 1,151 | 1,167 | 1,103 | 1,119 | -53 | -4.5% | 759,900 |
| 2023/01/16 | 1,206 | 1,224 | 1,138 | 1,172 | -78 | -6.2% | 823,700 |
| 2023/01/13 | 1,234 | 1,265 | 1,201 | 1,250 | +31 | +2.5% | 485,700 |
| 2023/01/12 | 1,317 | 1,322 | 1,212 | 1,219 | -96 | -7.3% | 724,400 |
| 2023/01/11 | 1,349 | 1,379 | 1,305 | 1,315 | -34 | -2.5% | 421,500 |
| 2023/01/10 | 1,325 | 1,350 | 1,216 | 1,349 | -6 | -0.4% | 962,100 |
| 2023/01/06 | 1,221 | 1,371 | 1,213 | 1,355 | +126 | +10.3% | 861,800 |
| 2023/01/05 | 1,210 | 1,240 | 1,175 | 1,229 | +18 | +1.5% | 341,900 |
| 2023/01/04 | 1,275 | 1,299 | 1,195 | 1,211 | -61 | -4.8% | 734,800 |
| 2022/12/30 | 1,218 | 1,281 | 1,185 | 1,272 | +84 | +7.1% | 876,800 |
| 2022/12/29 | 1,185 | 1,203 | 1,142 | 1,188 | +3 | +0.3% | 335,400 |
| 2022/12/28 | 1,147 | 1,220 | 1,118 | 1,185 | +23 | +2% | 653,000 |
| 2022/12/27 | 1,049 | 1,177 | 1,042 | 1,162 | +137 | +13.4% | 528,500 |
| 2022/12/26 | 998 | 1,030 | 930 | 1,025 | +40 | +4.1% | 249,400 |
| 2022/12/23 | 990 | 996 | 962 | 985 | -15 | -1.5% | 79,600 |
| 2022/12/22 | 976 | 1,020 | 965 | 1,000 | +17 | +1.7% | 143,800 |
| 2022/12/21 | 977 | 1,009 | 960 | 983 | +7 | +0.7% | 153,600 |
| 2022/12/20 | 983 | 1,007 | 945 | 976 | -24 | -2.4% | 168,400 |
| 2022/12/19 | 1,025 | 1,052 | 989 | 1,000 | -35 | -3.4% | 190,300 |
| 2022/12/16 | 1,028 | 1,087 | 1,014 | 1,035 | +7 | +0.7% | 357,200 |
| 2022/12/15 | 984 | 1,040 | 984 | 1,028 | +44 | +4.5% | 163,800 |
| 2022/12/14 | 988 | 1,015 | 980 | 984 | -5 | -0.5% | 201,000 |
| 2022/12/13 | 934 | 999 | 931 | 989 | +53 | +5.7% | 195,400 |
| 2022/12/12 | 941 | 980 | 927 | 936 | -4 | -0.4% | 202,900 |
| 2022/12/09 | 841 | 940 | 836 | 940 | +90 | +10.6% | 359,300 |
| 2022/12/08 | 845 | 855 | 811 | 850 | +10 | +1.2% | 230,800 |
| 2022/12/07 | 966 | 972 | 840 | 840 | -36 | -4.1% | 967,900 |
| 2022/12/06 | 853 | 876 | 843 | 876 | +11 | +1.3% | 49,300 |
| 2022/12/05 | 865 | 865 | 841 | 865 | -3 | -0.3% | 38,300 |
| 2022/12/02 | 847 | 878 | 841 | 868 | +16 | +1.9% | 42,700 |
| 2022/12/01 | 870 | 870 | 849 | 852 | -14 | -1.6% | 37,900 |
| 2022/11/30 | 890 | 890 | 859 | 866 | -26 | -2.9% | 51,100 |
| 2022/11/29 | 820 | 897 | 805 | 892 | +57 | +6.8% | 122,700 |
| 2022/11/28 | 864 | 867 | 835 | 835 | -29 | -3.4% | 54,000 |
| 2022/11/25 | 830 | 868 | 820 | 864 | +64 | +8% | 215,400 |
| 2022/11/24 | 794 | 810 | 794 | 800 | +7 | +0.9% | 63,300 |
| 2022/11/22 | 811 | 820 | 791 | 793 | -18 | -2.2% | 96,300 |
| 2022/11/21 | 834 | 834 | 795 | 811 | -27 | -3.2% | 220,300 |
| 2022/11/18 | 898 | 898 | 838 | 838 | -150 | -15.2% | 380,800 |
| 2022/11/17 | 1,002 | 1,012 | 980 | 988 | -21 | -2.1% | 33,200 |
| 2022/11/16 | 973 | 1,011 | 973 | 1,009 | +30 | +3.1% | 30,200 |
| 2022/11/15 | 952 | 985 | 934 | 979 | +4 | +0.4% | 52,600 |
| 2022/11/14 | 971 | 981 | 955 | 975 | -5 | -0.5% | 28,900 |
601～
650
件表示中 / 1643件
類似銘柄と比較する
現在ご覧いただいている「ＤＥＬＴＡ－Ｐ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＤＥＬＴＡ－Ｐ | 70,600円 | - | - | 0.00% | - | 28.05倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
| ＰＲＩＳＭＢｉｏ | 23,000円 | +14.8% | - | 0.00% | - | 2.76倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
| ケイファーマ | 72,500円 | - | - | 0.00% | - | 3.73倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞による再生医療と創薬の２本柱。中枢神経系が得意領域 |
| ＯＴＳ | 2,900円 | +33.3% | - | 0.00% | - | 12.24倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
| ノイルイミューン | 17,600円 | -28.6% | - | 0.00% | - | 1.62倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
市場注目の銘柄
チャート関連のコラム
